Clear cell adenocarcinoma of the ovary

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

10 events
Jan 2026Liposomal Irinotecan Combined With Sintilimab and Anlotinib in the Treatment of Recurrent or Persistent Ovarian Clear Cell Carcinoma

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University — PHASE2

TrialNOT YET RECRUITING
Jun 2025INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell Carcinoma

Tongji Hospital — PHASE3

TrialNOT YET RECRUITING
Dec 2024Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin

Dana-Farber Cancer Institute — PHASE2

TrialRECRUITING
Nov 2023Safety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100

M.D. Anderson Cancer Center — PHASE1, PHASE2

TrialRECRUITING
Mar 2023A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the Ovary

Tongji Hospital

TrialRECRUITING
Sep 2022Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer

Elizabeth K. Lee MD — PHASE2

TrialACTIVE NOT RECRUITING
Jul 2022A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies

Xencor, Inc. — PHASE2

TrialACTIVE NOT RECRUITING
Dec 2021A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer

Nuvectis Pharma, Inc. — PHASE1

TrialACTIVE NOT RECRUITING
Sep 2019A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Novartis Pharmaceuticals — PHASE1, PHASE2

TrialRECRUITING
May 2019Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer

National Cancer Institute (NCI) — PHASE2

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

1

Copay cards

Copay Assistance1

Hexalen

Medimmune Oncology, Inc.

OpenContact for details

View all support programs on disease page →

Clinical Trial Landscape

8 active trials
4Phase 2
1Phase 1
1Unknown
2PHASE1, PHASE2
8Total recruiting
Search clinical trials for Clear cell adenocarcinoma of the ovary

Recent News & Research

No recent news articles indexed yet for Clear cell adenocarcinoma of the ovary.
Search PubMed for Clear cell adenocarcinoma of the ovary

Browse all Clear cell adenocarcinoma of the ovary news →

Specialist Network

Top 6 by expertise

View all Clear cell adenocarcinoma of the ovary specialists →

Quick Actions